Insufficient Scientific Evidence Supporting the Use of Ivermectin in the Prevention and Treatment of COVID-19

Main Article Content

Sohail Rao
Alec Vasquez-Kanhere
Manish Singh


COVID-19, Ivermectin, SARS-CoV-2, COVID-19 Vaccine, CDC, FDA, AMA, NIH

Abstract 43 | PDF Downloads 332


1. Zaidi, A.K., Dehgani-Mobaraki, P. The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article. J Antibiot (2021).
2. Caly, L., Druce, J.D., The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020; 178:104787.
3. Offord, C. Frontiers Pulls Special COVID-19 Issue After Content Dispute. The Scientist. 2021.
4. Popp, M., Stegemann, M., et. al. Ivermectin for preventing and treating COVID-19. Cochrane Database of Systematic Reviews 2021, Issue 7. Art, No: CD015017. DO1:
5. Why You Should Not Use Ivermectin to Treat or Prevent COVID-19. 2021.
6. U.S. Centers for Disease Control & Prevention. Emergency Preparedness and Response. Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19. 2021.
7. Texas Poison Center Calls Triple for People Treating COVID-19 With Ivermectin. 2021.
8. AMA, APhA, ASHP statement on ending use of Ivermectin to treat COVID-19. 2021.

Most read articles by the same author(s)

1 2 > >>